11:19 AM
 | 
Oct 18, 2018
 |  BC Innovations  |  Distillery Techniques

Biomarkers

TECHNOLOGY: Plasma markers; tissue markers

CSF levels of mutant HTT, and CSF or plasma levels of NEFL , could help diagnose HD and differentiate between manifest and premanifest disease. In 20 premanifest HD patients, 40 manifest HD patients and 20 healthy volunteers, CSF levels of mutant HTT,...

Read the full 211 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >